Alaska native family-based, financial incentives intervention for smoking cessation: an RCT
Active Project Grant Awarded Last action
- Award ID
- R01DA056469
- Recipient
-
Mayo Clinic UEI Y2K4F9RPRRG7 Part of Mayo Clinic
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,798,079
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date 76% complete
- Originally
- Funding
-
- $6,160,452.00 Federal
- $637,627.00 Non-federal
- Place of performance
- Rochester, MN 55905, USA
Award details come from USAspending.gov.
Description
- Abstract
- In alaska (AK), smoking prevalence of alaska native and american indian (anai) people is more than double that of non-native adults (37% VS. 17%). Unlike other indigenous populations, tobacco is not used in traditional ceremony. Current cessation strategies have not reduced smoking prevalence among anai people. AK geography (largely frontier and road-less) and climate further limit treatment access and reach. Based on behavioral economic theory, financial incentives to promote cessation is a promising approach in other populations, with smoking abstinence rates more than doubling one year after discontinued rewards compared with no incentives. Community input for this study indicate family members are essential in supporting smoking cessation; consistent with the anai cultural value of interdependence, defined as relationship-based, collaborative, and reliance on family systems rather than individuals. Our research and others' document the influence of naturally occurring social support networks on smoking cessation. Family-based incentive interventions have not been evaluated for smoking or other addictions. To fill this GAP, the proposed study will evaluate the effectiveness and implementation of a culturally-adapted, anai family-based incentives intervention for smoking cessation with the following specific aims: (1) adapt an effective 6-month financial incentive intervention for anai people who smoke and family members; (2) conduct a randomized controlled trial (RCT) to evaluate reach and effectiveness of the intervention compared with the control condition on confirmed, prolonged smoking abstinence at six and 12 months post-intervention; and (3) evaluate key process indicators relevant to intervention adoption, implementation, and maintenance, and conduct a cost- effectiveness analysis to support further adaptation and dissemination. RCT-enrolled dyads (adult anai person who smokes [index participant] and adult family member) will be stratified by index participant's SEX, rural/urban location, residence with family member, and by family member's smoking status, then randomized to a no incentives control condition (n=328 dyads) or a 6-month incentive intervention (n=328 dyads). All dyads will receive materials on evidence-based cessation resources, social support strategies, and family wellness. We will measure index participant smoking status in both groups weekly for four weeks, and at three and six months. Intervention index participants will receive rewards for verified smoking abstinence at each time point, up to $750; and the family member will receive rewards (e.g., fuel or other needs) equal to the value earned by the index participant. We will explore potential moderators (e.g., index participant SEX) and mediators (e.g., interdependence) of intervention effects. To enhance reach, we will recruit participants statewide, primarily with social media, and deliver the intervention virtually. If successful, our results will inform tribal policy to adopt the intervention within the AK tribal health system; and possibly, for use within anai communities beyond AK.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $560,688 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $62,205 | $0 | |
| Amendment | $62,205 | $0 | |
| Amendment | $559,854 | $0 | |
| Amendment | $559,854 | $0 | |
| Amendment | $559,854 | $0 | |
| Amendment | $627,637 | $0 | |
| Amendment | $627,637 | $0 | |
| Amendment | $627,637 | $0 | |
| Amendment | $637,627 | $0 | |
| Amendment | $637,627 | $637,627 | |
| Original award | $637,627 | $0 |
Show all 13
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Alaska Native Tribal Health Consortium | -$47,446 | |
| Alaska Native Tribal Health Consortium | $298,636 | |
| University Of Alaska Anchorage | $31,609 | |
| University Of Alaska Anchorage | $15,419 | |
| Alaska Native Tribal Health Consortium | $264,907 | |
| The Leland Stanford Junior University | $80,936 | |
| Washington State University | $79,448 |
Quick answers
Who received award R01DA056469?
R01DA056469 was awarded to Mayo Clinic by National Institute on Drug Abuse (National Institutes of Health) on May 1, 2022.
How much is award R01DA056469 worth?
$6,798,079 has been obligated on R01DA056469: $6,160,452 in federal funding and $637,627 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award